International study shows improved outcomes for psoriasis patients
Interim results from one of the largest and longest clinical trials ever conducted for a topical treatment in psoriasis* showed that after eight weeks of treatment with calcipotriol/betamethasone dipropionate (Daivobet® gel), the treatment was highly efficacious, preferred by patients and improved patients' and the physicians’ assessments of disease severity. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 29, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Rheumatology Patient care calcipotriol/betamethasone dipropionate Latest News psoriasis Source Type: news
Building a better world for people with psoriasis
On World Psoriasis Day, the International Federation of Psoriasis Associations, IFPA, brings attention to the tools respondents from 90 countries have identified to help build a better world for people with psoriasis, by participating in an online survey launched in June. The preliminary results of the survey show a clear consensus – the top tool voted for is Educating the patients about treatment options. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 29, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News Rheumatology Patient care IFPA Latest News online survey patient education psoriasis Source Type: news
The UKCPA Autumn Symposium
is endorsed by the Royal Pharmaceutical Society. This year, we are running 15 interactive work sessions on topics in both clinical and non-clinical areas. Come along to learn, share best practice, and meet the experts who have vast experience in these areas. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 24, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick European Conferences and Symposia Latest News ukcpa symposium Source Type: news
Designed for the future: the latest subsidiary trust pharmacy opens in North Tees
North Tees and Hartlepool NHS Foundation Trust unveiled its new outpatient pharmacy, Panacea, with a little help from pharmacy design specialists, T3. It is the latest NHS Foundation Trust to create a commercial arm (Optimus) to run its pharmacy, based at the University Hospital of North Tees in Stockton. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 24, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Policy & practice Latest News Optimus outpatient pharmacy Panacea pharmacy design Source Type: news
Lynparza™ (olaparib) receives positive CHMP opinion in the EU
AstraZeneca announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the marketing authorisation of Lynparza™ (olaparib) as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed BRCA-mutated (germline and/or somatic) high grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 24, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Industry News Oncology BRCA-mutated Latest News Lynparza olaparib ovarian cancer Source Type: news
Research suggests team-based care is most effective way to control hypertension
Patients diagnosed with high blood pressure are given better control of their condition from a physician-pharmacist collaborative intervention than physician management alone, according to new research. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 23, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News Patient care Policy & practice collaborative intervention hypertension Latest News team-based care Source Type: news
Bayer’s Adempas® receives ‘Highly Commended’ honour at 2014 Prix Galien Awards
Bayer HealthCare is delighted to announce that the innovative drug, Adempas, has received a Prix Galien Award – a High Commendation at the 2014 ceremony at The House of Commons. The bi-annual awards are designed to recognise the significant contribution the pharmaceutical industry makes in clinical research and drug development. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 21, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick European Conferences and Symposia Practical therapeutics Cost effectiveness Industry News Drug development CTEPH health outcomes Latest News pah riociguat SCG enzyme Source Type: news
Treeway B.V. and LACDR collaborate on ALS therapy development
Treeway and LACDR at the University of Leiden join forces and form a collaboration focused on the optimisation of clinical trial designs and data-analysis for ALS (Amyotrophic Lateral Sclerosis) through the use of population disease progression models. Furthermore both parties aim to obtain a better understanding of the disease by developing ALS physiology-based disease models and to test the effect of interventions in the different identified pathways. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 15, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Industry News clinical trial design disease progression models Latest News Source Type: news
Ulcerative colitis patients who have had a colectomy continue to experience symptoms
New research shows that the majority of patients with the challenging inflammatory bowel disease, ulcerative colitis (UC), state that the three biggest impacts of the disease on their lives are on their emotional state (in terms of depression, anger or anxiety levels) (76%), ability to get adequate rest/sleep (75%), and taking sick days off work (70%). Those who have had a colectomy (removal of the colon) were more likely to suffer from these impacts. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 13, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News Gastroenterology Patient care ibd Latest News nice ulcerative colitis Source Type: news
New findings from PSOLAR show persistency difference among biologic therapies
Janssen-Cilag International NV reported new findings at the annual meeting of the European Academy of Dermatology and Venereology (EADV) showing significantly better persistency and lower rates of discontinuation with STELARA® (ustekinumab) therapy in comparison to anti-tumour necrosis factor (TNF)-alpha treatments among patients participating in Psoriasis Longitudinal Assessment and Registry (PSOLAR), a post-marketing registry following patients with moderate to severe plaque psoriasis. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 13, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News Dermatology Rheumatology psoriasis TNF-alpha ustekinumab Source Type: news
Bayer remains committed to supporting NHS with improved access to Sativex®
Bayer HealthCare announces it is pleased that the National Institute for Health and Care Excellence (NICE) clinical guideline for the management of Multiple Sclerosis (MS) in primary and secondary care (CG186) recognises the multi-faceted nature of the disease and the complex needs of people with MS. Bayer welcomes the recommendation that MS patients should have a single point of contact and a comprehensive annual review but are disappointed that the guideline did not recommend Sativex® as a treatment option for moderate to severe spasticity. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 10, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Cost effectiveness Industry News Central Nervous System Latest News multiple sclerosis oromucosal spray Sativex spasticity Source Type: news
News from The City of Liverpool College
City of Liverpool College apprentice Brett Finch won the "Best Academic" category of the Health Education North West Pharmacy Technician Awards, in recognition of his work as a Pharmacy Technician. www.liv-coll.ac.uk (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 9, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News City of Liverpool College Health education North West Pharmacy Technician Awards Latest News Source Type: news
Pharmacists lead the way in streamlining experimental cancer trials
A new way of conducting technical pharmacy reviews that cuts down on the bureaucracy of setting up clinical trials is being pioneered by pharmacists across the Experimental Cancer Medicine Centres (ECMCs) network, a joint initiative between Cancer Research UK and the four health departments of the UK. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 8, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Association News Clinical trials Oncology CRUK ECMC Latest News pharmacy review Source Type: news
Pfizer launches medicines optimisation scratch card
A medicines optimisation scratch card launched by Pfizer at the Pharmacy Show, aims to increase patient engagement with the pharmacy team and create opportunities to engage patients with pharmacy services such as medicines use reviews (MURs) and new medicines service (NMS). (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 6, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Industry News Policy & practice Latest News medicine use review new medicines service optimisation pharmacy services Source Type: news
Data presented at EURETINA 2014 showcase efficacy of EYLEA in clinical practice
Bayer HealthCare reports that data have been presented at the 14th EURETINA congress in London, showcasing the efficacy of EYLEA® (aflibercept solution for injection) for the treatment of wet age-related macular degeneration (wAMD) in the real-life setting. Numerous posters presented at the congress, from centres across the UK, highlight that treatment with EYLEA has resulted in improved visual and/or anatomical outcomes in treatment-naïve and pre-treated patients. (Source: Pharmacy Europe)
Source: Pharmacy Europe - October 6, 2014 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Industry News Ophthalmology aflibercept central retinal thickness Latest News visual acuity wet age-related macular degeneration Source Type: news
